Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(10)
DRUG(6)
PROCEDURE(2)
Cediranib
2 trials
not_applicablephase_2
university-health-network-toronto
Tumour tissue collection
2 trials
not_applicable
university-health-network-toronto
Olaparib
2 trials
not_applicablephase_2
university-health-network-toronto
ENMD-2076
1 trial
phase_2
university-health-network-toronto
Ascites Collection
1 trial
not_applicable
university-health-network-toronto
DPX-Survivac
1 trial
phase_2
university-health-network-toronto
Cyclophosphamide
1 trial
phase_2
university-health-network-toronto
Blood draws
1 trial
not_applicable
university-health-network-toronto

+7 more interventions

15 unique interventions3 categories

Analytics

Trial Phases

Phase 23

Trial Status

Completed7
Recruiting2
Other1

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT06254781Not ApplicableCompleted
Luspatercept in Metastatic AGCT of the Ovary
Adult Granulosa Cell Tumor of the Ovary
PrincipalinvestigatorStart date: 2022-05-30
NCT06328491Not ApplicableCompleted
Erdafitinib in Metastatic Steroid-cell Ovarian Cancer
Ovarian CancerSteroid Cell Tumor, Malignant
PrincipalinvestigatorStart date: 2022-05-30
NCT03029403Phase 2Active Not Recruiting
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Advanced CancerFallopian Tube CancerOvarian Cancer+1 more
PrincipalinvestigatorStart date: 2018-02-12
NCT03419689Not ApplicableRecruiting
Study Looking at Biomarkers in Ovarian Cancer
Gynecologic Cancer
PrincipalinvestigatorStart date: 2018-01-08
NCT03420118Not ApplicableRecruiting
Study of Biomarkers in Gynecological Cancers
Gynecologic Cancer
PrincipalinvestigatorStart date: 2017-12-21
NCT02952521Completed
Ovarian Tumor Biopsies to Study Response to Treatments
Epithelial Ovarian Cancer
PrincipalinvestigatorStart date: 2017-01-25
NCT02681237Not ApplicableCompleted
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
Ovarian Cancer
PrincipalinvestigatorStart date: 2016-04-29
NCT02489058Completed
A Study of Long-Term Responders on Olaparib
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
PrincipalinvestigatorStart date: 2016-02-01
NCT01914510Phase 2Completed
A Study of ENMD-2076 in Ovarian Clear Cell Cancers
Ovarian Clear Cell Carcinoma
Principalinvestigator
NCT02340611Phase 2Completed
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib
Ovarian Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Sabbatini, MD

Memorial Sloan Kettering Cancer Center

Related
14 trials

Shared therapeutic areas:

Ovary CancerFallopian Tube CancerPeritoneal Cancer+1 more
Similarity Score12%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Carcinoma, Ovarian EpithelialOvary CancerGynecologic Cancer
Similarity Score9%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Fallopian Tube CancerOvary CancerPeritoneal Cancer
Similarity Score9%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Carcinoma, Ovarian EpithelialOvary Cancer
Similarity Score6%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced CancerPrimary Peritoneal Carcinoma
Similarity Score6%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score3%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score3%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Advanced Cancer
Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Ovary Cancer

Worked with same sponsors:

AstraZeneca
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06254781Not ApplicablePrincipalInvestigator

Luspatercept in Metastatic AGCT of the Ovary

Adult Granulosa Cell Tumor of the Ovary
Completed
NCT06328491Not ApplicablePrincipalInvestigator

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

Ovarian CancerSteroid Cell Tumor, Malignant
Completed
NCT03029403Phase 2PrincipalInvestigator

Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Advanced CancerFallopian Tube CancerOvarian Cancer+1 more
Active Not Recruiting
NCT03419689Not ApplicablePrincipalInvestigator

Study Looking at Biomarkers in Ovarian Cancer

Gynecologic Cancer
Recruiting
NCT03420118Not ApplicablePrincipalInvestigator

Study of Biomarkers in Gynecological Cancers

Gynecologic Cancer
Recruiting
NCT02952521PrincipalInvestigator

Ovarian Tumor Biopsies to Study Response to Treatments

Epithelial Ovarian Cancer
Completed
NCT02681237Not ApplicablePrincipalInvestigator

A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer

Ovarian Cancer
Completed
NCT02489058PrincipalInvestigator

A Study of Long-Term Responders on Olaparib

Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Completed
NCT01914510Phase 2PrincipalInvestigator

A Study of ENMD-2076 in Ovarian Clear Cell Cancers

Ovarian Clear Cell Carcinoma
Completed
NCT02340611Phase 2PrincipalInvestigator

A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib

Ovarian Cancer
Completed

All 10 trials loaded